Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fenli Shao

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
International Immunopharmacology|January 29, 2026
A novel mouse model of arthritis with enthesitis and heterotopic ossificationShanshan Kang, Shuqiong Zhang, Xingyi Wang, et al.
Nature Communications|November 18, 2016
CUG-binding protein 1 regulates HSC activation and liver fibrogenesisXingxin Wu, Xudong Wu, Yuxiang Ma, et al.
Journal of Pharmacological Sciences|September 1, 2015
Fumigaclavine C ameliorates dextran sulfate sodium-induced murine experimental colitis via NLRP3 inflammasome inhibitionWenjie Guo, Shasha Hu, Ahmed Elgehama, et al.
Nature Communications|November 12, 2021
Targeting chondrocytes for arresting bony fusion in ankylosing spondylitisFenli Shao, Qianqian Liu, Yuyu Zhu, et al.
Biochemical Pharmacology|October 22, 2016
A fumigaclavine C isostere alleviates Th1-mediated experimental colitis via competing with IFN-γ for binding to IFN-γ receptor 1Yang Tan, Xingxin Wu, Jing Sun, et al.
Nature Communications|February 7, 2025
Author Correction: Targeting chondrocytes for arresting bony fusion in ankylosing spondylitisFenli Shao, Qianqian Liu, Yuyu Zhu, et al.
EMBO Molecular Medicine|December 22, 2021
Allosteric inhibition of SHP2 uncovers aberrant TLR7 trafficking in aggravating psoriasisYuyu Zhu, Zhigui Wu, Wei Yan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2018
Targeting Peroxiredoxin 1 by a Curcumin Analogue, AI-44, Inhibits NLRP3 Inflammasome Activation and Attenuates Lipopolysaccharide-Induced Sepsis in MiceWen Liu, Wenjie Guo, Yongcheng Zhu, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
International Immunopharmacology|January 29, 2026
A novel mouse model of arthritis with enthesitis and heterotopic ossificationShanshan Kang, Shuqiong Zhang, Xingyi Wang, et al.
Nature Communications|November 18, 2016
CUG-binding protein 1 regulates HSC activation and liver fibrogenesisXingxin Wu, Xudong Wu, Yuxiang Ma, et al.
Journal of Pharmacological Sciences|September 1, 2015
Fumigaclavine C ameliorates dextran sulfate sodium-induced murine experimental colitis via NLRP3 inflammasome inhibitionWenjie Guo, Shasha Hu, Ahmed Elgehama, et al.
Nature Communications|November 12, 2021
Targeting chondrocytes for arresting bony fusion in ankylosing spondylitisFenli Shao, Qianqian Liu, Yuyu Zhu, et al.
Biochemical Pharmacology|October 22, 2016
A fumigaclavine C isostere alleviates Th1-mediated experimental colitis via competing with IFN-γ for binding to IFN-γ receptor 1Yang Tan, Xingxin Wu, Jing Sun, et al.
Nature Communications|February 7, 2025
Author Correction: Targeting chondrocytes for arresting bony fusion in ankylosing spondylitisFenli Shao, Qianqian Liu, Yuyu Zhu, et al.
EMBO Molecular Medicine|December 22, 2021
Allosteric inhibition of SHP2 uncovers aberrant TLR7 trafficking in aggravating psoriasisYuyu Zhu, Zhigui Wu, Wei Yan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2018
Targeting Peroxiredoxin 1 by a Curcumin Analogue, AI-44, Inhibits NLRP3 Inflammasome Activation and Attenuates Lipopolysaccharide-Induced Sepsis in MiceWen Liu, Wenjie Guo, Yongcheng Zhu, et al.
Pageof 2